Skip to main content

MoneyWorks4Me

Goldline Pharmaceutical informs about disclosure

30 Jul 2026 Evaluate
Goldline Pharmaceutical has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prashant Shrikrishna Karkare.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Redington 331.25
Adani Enterprises 2710.00
Amrapali Industries 32.78
Maxgrow India 158.55
Rashi Peripheral 650.00
View more..